Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00XQK
|
||||
| Former ID |
DIB003722
|
||||
| Drug Name |
HRC-102
|
||||
| Synonyms |
Hemolox T; HML-110
|
||||
| Indication | Reperfusion injury [ICD10:I00-I99] | Terminated | [547482] | ||
| Company |
Ontario Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Hemoglobin | Target Info | Modulator | [550172] | |
| KEGG Pathway | African trypanosomiasis | ||||
| Malaria | |||||
| WikiPathways | Binding and Uptake of Ligands by Scavenger Receptors | ||||
| Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | |||||
| Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes | |||||
| Factors involved in megakaryocyte development and platelet production | |||||
| Folate Metabolism | |||||
| Vitamin B12 Metabolism | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.